help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 20, 2008, doi:10.1164/rccm.200712-1807OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200712-1807OCv1
177/12/1377    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sztrymf, B.
Right arrow Articles by Humbert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sztrymf, B.
Right arrow Articles by Humbert, M.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 1377-1383, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200712-1807OC

Original Article

Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation

Benjamin Sztrymf1, Florence Coulet2, Barbara Girerd1, Azzedine Yaici1, Xavier Jais1, Olivier Sitbon1, David Montani1, Rogério Souza1, Gerald Simonneau1, Florent Soubrier2 and Marc Humbert1

1 Université Paris-Sud 11, UPRES EA 2705, Centre National de Référence de l'Hypertension Artérielle Pulmonaire, Service de Pneumologie et Réanimation Respiratoire, Institut Paris-Sud Cytokines, Hôpital Antoine-Béclère, Assistance Publique des Hôpitaux de Paris, Clamart, France; and 2 Université Pierre et Marie Curie–Paris 6, Laboratoire d'Oncogénétique et Angiogénétique Moléculaire, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

Correspondence and requests for reprints should be addressed to Marc Humbert, M.D., Ph.D., Service de Pneumologie et Réanimation Respiratoire, Hôpital Antoine-Béclère, 157 rue de la Porte de Trivaux, 92140 Clamart, France. E-mail: marc.humbert{at}abc.aphp.fr

Rationale: Germline mutations in the gene encoding for bone morphogenetic protein receptor 2 (BMPR2) are a cause of pulmonary arterial hypertension (PAH).

Objectives: We conducted a study to determine the influence, if any, of a BMPR2 mutation on clinical outcome.

Methods: The French Network of Pulmonary Hypertension obtained data for 223 consecutive patients displaying idiopathic or familial PAH in whom point mutation and large size rearrangements of BMPR2 were screened for. Clinical, functional, and hemodynamic characteristics, as well as outcomes, were compared in BMPR2 mutation carriers and noncarriers.

Measurements and Main Results: Sixty-eight BMPR2 mutation carriers (28 familial and 40 idiopathic PAH) were compared with 155 noncarriers (all displaying idiopathic PAH). As compared with noncarriers, BMPR2 mutation carriers were younger at diagnosis of PAH (36.5 ± 14.5 vs. 46.0 ± 16.1 yr, P < 0.0001), had higher mean pulmonary artery pressure (64 ± 13 vs. 56 ± 13 mm Hg, P < 0.0001), lower cardiac index (2.13 ± 0.68 vs. 2.50 ± 0.73 L/min/m2, P = 0.0005), higher pulmonary vascular resistance (17.4 ± 6.1 vs. 12.7 ± 6.6 mm Hg/L/min/m2, P < 0.0001), lower mixed venous oxygen saturation (59 ± 9% vs. 63 ± 9%, P = 0.02), shorter time to death or lung transplantation (P = 0.044), and younger age at death (P = 0.002), but similar overall survival (P = 0.51).

Conclusions: BMPR2 mutation carriers with PAH present approximately 10 years earlier than noncarriers, with a more severe hemodynamic compromise at diagnosis.

Key Words: bone morphogenetic protein receptor 2 • genetics • hemodynamics • pulmonary arterial hypertension • survival


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Germline mutations in the gene encoding for bone morphogenetic protein receptor 2 (BMPR2) are a cause of pulmonary arterial hypertension. The influence, if any, of a BMPR2 mutation on clinical outcomes is currently unknown.

What This Study Adds to the Field
BMPR2 mutation carriers with pulmonary arterial hypertension present approximately 10 years earlier than noncarriers with a more severe hemodynamic compromise at diagnosis.

 

Related articles in AJRCCM:

BMPR2 Mutation and Outcome in Pulmonary Arterial Hypertension: Clinical Relevance to Physicians and Patients
Lewis J. Rubin
AJRCCM 2008 177: 1300-1301. [Full Text]  



This article has been cited by other articles:


Home page
 Eur Respir JHome page
L. Dewachter, S. Adnot, C. Guignabert, L. Tu, E. Marcos, E. Fadel, M. Humbert, P. Dartevelle, G. Simonneau, R. Naeije, et al.
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension
Eur. Respir. J., November 1, 2009; 34(5): 1100 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
L. B. Ware
Clinical Year in Review I: Interstitial Lung Disease, Pulmonary Vascular Disease, Pulmonary Infections, and Cardiopulmonary Exercise Testing and Pulmonary Rehabilitation
Proceedings of the ATS, September 15, 2009; 6(6): 487 - 493.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. D. Machado, O. Eickelberg, C. G. Elliott, M. W. Geraci, M. Hanaoka, J. E. Loyd, J. H. Newman, J. A. Phillips III, F. Soubrier, R. C. Trembath, et al.
Genetics and genomics of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S32 - S42.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Simonneau, I. M. Robbins, M. Beghetti, R. N. Channick, M. Delcroix, C. P. Denton, C. G. Elliott, S. P. Gaine, M. T. Gladwin, Z.-C. Jing, et al.
Updated clinical classification of pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S43 - S54.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. A. Ghofrani, R. J. Barst, R. L. Benza, H. C. Champion, K. A. Fagan, F. Grimminger, M. Humbert, G. Simonneau, D. J. Stewart, C. Ventura, et al.
Future perspectives for the treatment of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S108 - S117.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. G. Elliott, L. Brown, M. Hegewald, and P. Zimmerman
A Pathogenetic Paradigm for Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 967 - 967.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. E. Faughnan, J. T. Granton, and L. H. Young
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia
Eur. Respir. J., May 1, 2009; 33(5): 1186 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1573 - 1619.
[Full Text] [PDF]

Home page
 CirculationHome page
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation, April 28, 2009; 119(16): 2250 - 2294.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Hypertension 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 650 - 656.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Yndestad, K.-O. Larsen, E. Oie, T. Ueland, C. Smith, B. Halvorsen, I. Sjaastad, O. H. Skjonsberg, T. M. Pedersen, O.-G. Anfinsen, et al.
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol, April 1, 2009; 106(4): 1356 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
M. Humbert
More pressure on pulmonary hypertension
Eur. Respir. Rev., March 1, 2009; 18(111): 1 - 3.
[Full Text] [PDF]

Home page
 ERRHome page
R. Souza and C. Jardim
Trends in pulmonary arterial hypertension
Eur. Respir. Rev., March 1, 2009; 18(111): 7 - 12.
[Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
N. Galiè and A. Manes
CHAPTER 24 Pulmonary Hypertension
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Humbert and M. M. Hoeper
Severe Pulmonary Arterial Hypertension: A Forme Fruste of Cancer?
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 551 - 552.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. J. Rubin
BMPR2 Mutation and Outcome in Pulmonary Arterial Hypertension: Clinical Relevance to Physicians and Patients
Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1300 - 1301.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society 		  ATS 2008 State of the Art Course